NCT05453760

Brief Summary

The perioperative management of esophageal cancer has evolved considerably in recent years. Over the last 30 years, postoperative mortality has been steadily decreasing. However, respiratory morbidity remains high (30-40%). This is due to the procedure itself requiring a thoracic approach and intraoperative unipulmonary ventilation. The postoperative pulmonary complications (PPCs) are multiple: bronchial congestion, atelectasis, pneumopathy, acute respiratory failure, liquid pleural effusion, pneumothorax. In general, prevention and early treatment are aimed at limiting the evolution towards acute respiratory failure requiring ventilatory assistance. Chest radiography is essential for the presumptive diagnosis of pneumopathy in particular, but the interpretation of the images may be difficult. Thoracic computed tomography (CT) is the gold standard because it is sensitive and can discriminate among differential diagnoses. This is difficult to perform: it requires intra-hospital transport of patient, who is often in acute respiratory failure, and the availability of an examination area. Lung ultrasound is used at the bedside for diagnosis of lung infection in intensive care unit. This has a sensitivity close to thoracic CT and has the advantage of being feasible at any time, does not require transport of the patient and is not irradiating. Lung ultrasound allows early detection of the need for ventilatory support in postoperative major abdominal surgery . In addition, the sensitivity of lung ultrasound is close to that of CT, allowing this examination to be relied upon. The main objective of the study is to determine the role of lung ultrasound (LUS) in the prediction of postoperative pulmonary complications within one hour after extubation. The secondary objectives are to determine the performance of lung and diaphragmatic ultrasound (DUS) on postoperative day 1 and to establish a predictive model integrating LUS, DUS, and clinical variables to improve early identification of patients at risk of postoperative pulmonary complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
274

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 7, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 12, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

August 22, 2022

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
Last Updated

January 15, 2026

Status Verified

January 1, 2026

Enrollment Period

2.7 years

First QC Date

July 7, 2022

Last Update Submit

January 13, 2026

Conditions

Keywords

Thoracic EsophagectomyEsophagectomyPostoperative pulmonary complicationslung ultrasoundcritical care

Outcome Measures

Primary Outcomes (1)

  • Area under the curve (AUC) of the Lung ultrasound score

    at Day 0 (within 1 hour of tracheal extubation)

Secondary Outcomes (10)

  • Area under the curve (AUC) of the Lung ultrasound score at Day 1

    Day 1

  • Diaphragmatic excursion is measured via subcostal diaphragmatic ultrasound performed during the patient's clinical examination

    at Day 0, Day 1 and Day 3

  • The presence of condensations on pleuropulmonary ultrasound in the ICU

    at Day 0, Day 1 and Day 3

  • The presence of pleural effusion at D0, D1 or D3

    at Day 0, Day 1 and Day 3

  • Complications according to the Dindo-Clavien classification

    at Day 7

  • +5 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Prospective cohort study of esophagectomy patients in a tertiary hospital

You may qualify if:

  • Thoracic Esophagectomy

You may not qualify if:

  • Emphysema Death during surgery Refusal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hop Claude Huriez Chu Lille

Lille, France

Location

MeSH Terms

Conditions

Esophageal Neoplasms

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsDigestive System DiseasesEsophageal DiseasesGastrointestinal Diseases

Study Officials

  • Cédric CIRENEI, MD,PhD

    University Hospital, Lille

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 7, 2022

First Posted

July 12, 2022

Study Start

August 22, 2022

Primary Completion

April 30, 2025

Study Completion

April 30, 2025

Last Updated

January 15, 2026

Record last verified: 2026-01

Locations